- Report
- January 2026
- 138 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- February 2026
- 100 Pages
Africa, Middle East
From €4439EUR$4,799USD£3,704GBP
- Report
- April 2026
- 180 Pages
Middle East, Africa
From €5503EUR$5,950USD£4,593GBP
- Report
- April 2026
- 180 Pages
Latin America
From €5503EUR$5,950USD£4,593GBP
- Report
- February 2026
- 180 Pages
Asia Pacific
From €6706EUR$7,250USD£5,596GBP
- Report
- February 2026
- 180 Pages
Europe
From €6706EUR$7,250USD£5,596GBP
- Report
- February 2026
- 180 Pages
North America
From €6706EUR$7,250USD£5,596GBP
- Report
- April 2026
- 148 Pages
Middle East
From €3699EUR$3,999USD£3,087GBP
- Report
- March 2026
- 139 Pages
United States
From €3699EUR$3,999USD£3,087GBP
- Report
- July 2026
- 125 Pages
Europe
From €4393EUR$4,750USD£3,666GBP
- Report
- May 2026
- 180 Pages
United States
From €4393EUR$4,750USD£3,666GBP
- Report
- February 2026
- 108 Pages
Europe
From €5545EUR$5,995USD£4,627GBP
- Report
- February 2026
- 85 Pages
North America
From €5545EUR$5,995USD£4,627GBP
- Report
- March 2026
- 150 Pages
United States
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 220 Pages
United States
From €4486EUR$4,850USD£3,744GBP
- Report
- February 2026
- 388 Pages
United States
From €4486EUR$4,850USD£3,744GBP
- Report
- April 2026
North America
From €3191EUR$3,450USD£2,663GBP
- Report
- April 2026
Europe
From €3191EUR$3,450USD£2,663GBP
- Report
- April 2026
Asia Pacific
From €3191EUR$3,450USD£2,663GBP
- Report
- April 2026
Middle East, Africa
From €3191EUR$3,450USD£2,663GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more